MetLife, Inc. (NYSE:MET – Get Free Report) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 6,420,000 shares, a drop of 12.8% from the February 28th total of 7,360,000 shares. Currently, 1.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 3,470,000 shares, the short-interest ratio is currently 1.9 days.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on the company. Piper Sandler lifted their price target on MetLife from $92.00 to $94.00 and gave the stock an “overweight” rating in a research report on Wednesday. Cowen restated a “buy” rating on shares of MetLife in a report on Friday, March 7th. Morgan Stanley upped their price target on shares of MetLife from $101.00 to $109.00 and gave the company an “overweight” rating in a report on Friday, February 28th. BMO Capital Markets began coverage on shares of MetLife in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price objective for the company. Finally, Wells Fargo & Company boosted their target price on MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research report on Wednesday, February 19th. Two research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, MetLife has an average rating of “Moderate Buy” and an average price target of $94.85.
Get Our Latest Research Report on MetLife
Institutional Inflows and Outflows
MetLife Stock Down 8.1 %
Shares of MetLife stock opened at $75.80 on Friday. MetLife has a 1 year low of $67.30 and a 1 year high of $89.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market cap of $51.64 billion, a price-to-earnings ratio of 12.70, a PEG ratio of 0.65 and a beta of 1.04. The firm’s 50-day moving average is $82.76 and its two-hundred day moving average is $82.96.
MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, research analysts expect that MetLife will post 9.65 earnings per share for the current fiscal year.
MetLife Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th were paid a $0.545 dividend. The ex-dividend date of this dividend was Tuesday, February 4th. This represents a $2.18 annualized dividend and a yield of 2.88%. MetLife’s dividend payout ratio (DPR) is presently 36.52%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- The 3 Best Fintech Stocks to Buy Now
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- How to start investing in penny stocks
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.